NEW DELHI: India is in its fourth phase of the national lockdown which will be ending on May 31. As of now, the country crossed the 1.50 lakh mark in terms of total coronavirus tally. In the period of one day, the country reported around 6,387 cases in total. The total tally of the nation is at 1,51,767.
The death toll rose to 4,337 today i.e. Wednesday, May 27. In the last 24 hrs, a total of 170 deaths were observed countrywide. Out of the total fatalities, 60 itself were reported from the state of Maharashtra.
There are 83,004 active coronavirus cases currently, as per the recent update on the website of Ministry of Health and Family Welfare. The recovery rate in the country has also improved significantly in the past few days. Over 42% of people out of the affected population have made a full recovery and have been discharged from medical facilities.
Maharashtra has become the first-ever state in India to go beyond the mark of 50,000 cases. On Tuesday, May 26 the state reported around 2,000 cases. The total tally is now at 54,758. The capital city, Mumbai itself comprises of 30,000 cases.
The national capital of India, Delhi also saw a spike in the number of cases being reported in the past few days. In the last 24 hours, there were around 412 new cases which got detected. The total tally of the state is now at 14,465.
Tamil Nadu also recorded around 646 new cases in the 24 hour time period. It is the second state to have the most coronavirus cases after Maharashtra. The total tally of the state is 17,728.
As the WHO (World Health Organisation) banned the testing of hydroxychloroquine for the treatment of coronavirus affected individuals, the ICMR (Indian Council of Medical Research) revealed that the use of the aforementioned drug has been approved in India based on the observational studies that took place. The anti-malaria medication will be used to treat the patients who are at high risk, as per Balram Bhargava, the director-general of ICMR.
He said, "What we found from observational studies and from case-control studies is that it may be working, and we also found that there were no major side-effects except nausea, vomiting and some palpitations. That was from the Indian Pharmacopoeia Commission."